Access Bio, the Kosdaq-listed in-vitro diagnostics company based in New Jersey that profited from selling Covid-19 testing kits, has had its legal victory overturned by a New Jersey court. The court's decision to invalidate a previous ruling in favor of Access Bio has reignited the case against Cali